Astec LifeSciences Limited — Others, 28-01-2025: Copy of Newspaper Publication

Astec LifeSciences Limited has announced a board meeting regarding the financial results for the quarter and nine months ended December 31, 2024. Total income from operations was ₹95.77 crore, while the net loss after tax amounted to ₹40.40 crore. This reflects a downturn compared to the previous year, indicating potential operational challenges. The company reported a net worth of ₹251.02 crore and a debt equity ratio of 2.05, which could raise concerns among investors regarding financial stability. Overall, this announcement suggests a cautious outlook for the company, given the significant losses.